翻訳と辞書 Words near each other ・ Emil Nanu ・ Emil Newman ・ Emil Nielsen ・ Emil Nikolaisen ・ Emil Ninu ・ Emil Nofal ・ Emil Jones ・ Emil Jones, III ・ Emil Josef Diemer ・ Emil Jula ・ Emil Julius Gumbel ・ Emil Juracka ・ Emil Jónsson ・ Emil Jönsson ・ Emil Jørgensen ・ Emil Kakkis ・ Emil Kaminsky ・ Emil Kang ・ Emil Kapaun ・ Emil Karas ・ Emil Karewicz ・ Emil Kaschub ・ Emil Kaufmann ・ Emil Kauppi ・ Emil Kazaz ・ Emil Kellenberger ・ Emil Kemény ・ Emil Kenzhesariyev ・ Emil Kessler ・ Emil Ketterer Dictionary Lists mini英和辞書 mini和英辞書 Webster 1913 Latin-English FOLDOC Wikipedia English ウィキペディア

翻訳と辞書　辞書検索 [ 開発暫定版 ] スポンサード リンク Emil Kakkis ： ウィキペディア英語版 Emil Kakkis Emil Kakkis M.D. Ph.D. (born 1960) is an American medical geneticist known for his work to develop treatments for ultra rare disorders. He is the President and Founder of the Kakkis EveryLife Foundation and Chief Executive Officer and President at Ultragenyx Pharmaceutical Inc. == Professional background == Kakkis began his work at Harbor-UCLA working with minimal funding and support to develop an enzyme replacement therapy (Aldurazyme) for the rare disorder Mucopolysaccharidosis (MPS I). The struggle to get the therapy translated from a successful canine model to patients succeeded due to the critical financial support of a patient organization formed by Mark and Jeanne Dant for their son Ryan, called the Ryan Foundation.〔()〕 Aldurazyme development was later supported by BioMarin and eventually their partner Genzyme leading to U.S. Food and Drug Administration (FDA) approval in 2003. During his tenure at BioMarin, Kakkis guided the development and approval of two more treatments for rare disorders, MPS VI and PKU and has contributed to the initiation of seven other treatment programs for rare disorders, three of which are now in clinical development. Kakkis is board certified in both Pediatrics and Medical Genetics. He graduated from Pomona College, magna cum laude, received combined MD and PhD degrees from the UCLA Medical Scientist Program and received the Bogen prize for his research. He completed a Pediatrics residency and Medical Genetics Training Fellowship at Harbor-UCLA Medical Center. He became an assistant professor of Pediatrics at Harbor-UCLA Medical Center from 1993 to 1998 where he initiated the enzyme therapy program for MPS I. 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Emil Kakkis」の詳細全文を読む スポンサード リンク 翻訳と辞書 : 翻訳のためのインターネットリソース Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.